Imo the CMO appointment is another box ticked on the due diligence list, along with the reduction in number of shareholders with unmarketable parcels. Look at the Dimerix website, the structure, the pipeline, the intellectual property held, the cash balance.... Everything is being lined up nicely.
- Forums
- ASX - By Stock
- Ann: CMO Appointment and Clinical Trials Update
Imo the CMO appointment is another box ticked on the due...
Featured News
Add DXB (ASX) to my watchlist
(20min delay)
|
|||||
Last
35.0¢ |
Change
-0.025(6.67%) |
Mkt cap ! $25.68M |
Open | High | Low | Value | Volume |
37.0¢ | 37.0¢ | 35.0¢ | $387.8K | 1.079M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 394907 | 35.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
36.5¢ | 15948 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 75000 | 0.086 |
4 | 139056 | 0.085 |
2 | 158037 | 0.084 |
1 | 50000 | 0.083 |
2 | 29695 | 0.082 |
Price($) | Vol. | No. |
---|---|---|
0.087 | 1995 | 1 |
0.090 | 50000 | 1 |
0.091 | 76873 | 1 |
0.092 | 99798 | 1 |
0.093 | 50000 | 1 |
Last trade - 16.10pm 12/12/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |